Drug Type Small molecule drug |
Synonyms CYD-6-28 |
Target |
Mechanism DR5 agonists(Tumor necrosis factor receptor superfamily member 10B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 01 Oct 2016 |